These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
221 related items for PubMed ID: 7954646
1. Milrinone, a cyclic AMP-phosphodiesterase inhibitor, has differential effects on regional myocardial work and oxygen consumption in experimental left ventricular hypertrophy. Chiu WC, Kedem J, Weiss HR, Tse J, Cheinberg BV, Scholz PM. Cardiovasc Res; 1994 Sep; 28(9):1360-5. PubMed ID: 7954646 [Abstract] [Full Text] [Related]
2. Relationship between cyclic-AMP content, regional myocardial function and O2 consumption in experimental left ventricular hypertrophy: effect of negative inotropes. Scholz PM, Chiu WC, Kedem J, Weiss HR. Life Sci; 1993 Sep; 53(24):1847-58. PubMed ID: 8246683 [Abstract] [Full Text] [Related]
3. Positive functional effects of milrinone and methylene blue are not additive in control and hypertrophic canine hearts. Leone RJ, Weiss HR, Scholz PM. J Surg Res; 1998 Jun; 77(1):23-8. PubMed ID: 9698527 [Abstract] [Full Text] [Related]
4. Myocardial effects of cyclic AMP phosphodiesterase inhibition are dampened in thyroxine-induced cardiac hypertrophy. Straznicka M, Leone RJ, Scholz PM, Weiss HR. J Surg Res; 1998 Apr; 76(1):61-6. PubMed ID: 9695741 [Abstract] [Full Text] [Related]
5. Effect of cyclic GMP reduction on regional myocardial mechanics and metabolism in experimental left ventricular hypertrophy. Guo X, Kedem J, Weiss HR, Tse J, Roitstein A, Scholz PM. J Cardiovasc Pharmacol; 1996 Mar; 27(3):392-400. PubMed ID: 8907801 [Abstract] [Full Text] [Related]
6. Down regulation of myocardial beta1-adrenoceptor signal transduction system in pacing-induced failure in dogs with aortic stenosis-induced left ventricular hypertrophy. Tse J, Huang MW, Leone RJ, Weiss HR, He YQ, Scholz PM. Mol Cell Biochem; 2000 Feb; 205(1-2):67-73. PubMed ID: 10821423 [Abstract] [Full Text] [Related]
7. Species-dependent pharmacodynamic effects of the selective low Km cyclic AMP phosphodiesterase III inhibitors WIN 58993 and WIN 62005. Dundore RL, Pagani ED, Bode DC, Bacon ER, Singh B, Lesher GY, Buchholz RA, Silver PJ. J Cardiovasc Pharmacol; 1995 Jan; 25(1):14-21. PubMed ID: 7723343 [Abstract] [Full Text] [Related]
8. The effect of intracoronary nitroprusside on cyclic GMP and regional mechanics is altered in a canine model of left ventricular hypertrophy. Roitstein A, Kedem J, Cheinberg B, Weiss HR, Tse J, Scholz PM. J Surg Res; 1994 Nov; 57(5):584-90. PubMed ID: 7967596 [Abstract] [Full Text] [Related]
9. Reduced effect of phenylephrine on regional myocardial function and O2 consumption in experimental LVH. Roitstein A, Cheinberg BV, Kedem J, Tse J, Weiss HR, Scholz PM. Am J Physiol; 1995 Mar; 268(3 Pt 2):H1202-7. PubMed ID: 7900873 [Abstract] [Full Text] [Related]
10. Effect of dopamine on regional myocardial function and oxygen consumption in experimental left ventricular hypertrophy. Wright C, Weiss HR, Kedem J, Scholz PM. Basic Res Cardiol; 1991 Mar; 86(5):449-60. PubMed ID: 1837451 [Abstract] [Full Text] [Related]
11. Regional oxygen supply and consumption balance in experimental left ventricular hypertrophy. Scholz PM, Grover GJ, Mackenzie JW, Weiss HR. Basic Res Cardiol; 1990 Mar; 85(6):575-84. PubMed ID: 2150167 [Abstract] [Full Text] [Related]
12. Pharmacologic and pharmacodynamic effects of the selective low Km cyclic AMP phosphodiesterase III inhibitors WIN 63291 and WIN 62582. Pagani ED, Dundore RL, Bode DC, Bacon ER, Singh B, Lesher GY, Buchholz RA, Silver PJ. J Cardiovasc Pharmacol; 1994 Sep; 24(3):403-10. PubMed ID: 7528296 [Abstract] [Full Text] [Related]
13. The oxygen wasting effect of isoproterenol is altered by chemical denervation and cardiac hypertrophy. Scholz PM, Kedem J, Cheinberg BV, Weiss HR. Basic Res Cardiol; 1996 Sep; 91(4):308-18. PubMed ID: 8874780 [Abstract] [Full Text] [Related]
14. Inhibition of phosphodiesterase type III before aortic cross-clamping preserves intramyocardial cyclic adenosine monophosphate during cardiopulmonary bypass. Janelle GM, Urdaneta F, Blas ML, Shryock J, Tang YS, Martin TD, Lobato EB. Anesth Analg; 2001 Jun; 92(6):1377-83. PubMed ID: 11375808 [Abstract] [Full Text] [Related]
15. Positive inotropy due to lowering cyclic GMP is also mediated by increases in cyclic AMP in control and hypertrophic hearts. Naim KL, Rabindranauth P, Weiss HR, Tse J, Leone RJ, Scholz PM. Can J Physiol Pharmacol; 1998 Jun; 76(6):605-12. PubMed ID: 9923398 [Abstract] [Full Text] [Related]
16. Comparative effects of R 80122, enoximone, and milrinone on left ventricular phosphodiesterase isoenzymes in vitro and on contractility of normal and stunned myocardium in vivo in dogs. Vandeplassche GM, Hermans CF, de Chaffoy de Courcelles DR, D'Aubioul JA, Wouters LJ, De Clerck FF. J Cardiovasc Pharmacol; 1992 May; 19(5):714-22. PubMed ID: 1381769 [Abstract] [Full Text] [Related]
17. The effect of reduced myocardial cyclic AMP content on the response to milrinone in the isolated guinea pig heart. Kehler CH, Hebl JR, Soule CL, Gallagher WJ, Houlton AJ. J Heart Lung Transplant; 1997 Jun; 16(6):636-42. PubMed ID: 9229294 [Abstract] [Full Text] [Related]
19. Cyclic GMP and cyclic AMP induced changes in control and hypertrophic cardiac myocyte function interact through cyclic GMP affected cyclic-AMP phosphodiesterases. Weiss HR, Gong GX, Straznicka M, Yan L, Tse J, Scholz PM. Can J Physiol Pharmacol; 1999 Jun; 77(6):422-31. PubMed ID: 10537228 [Abstract] [Full Text] [Related]
20. Effects of phosphodiesterase III inhibition on length-dependent regulation of myocardial function in coronary surgery patients. De Hert SG, ten Broecke PW, Mertens E, Rodrigus IE, Stockman BA. Br J Anaesth; 2002 Jun; 88(6):779-84. PubMed ID: 12173193 [Abstract] [Full Text] [Related] Page: [Next] [New Search]